Pyruvate
It can be further metabolized to acetyl-CoA, lactate, or alanine, and plays a central role in various physiological processes, including glucose homeostasis, mitochondrial function, and oxidative stress response.
Pyruvate research is crucial for understanding metabolic disorders, neurodegenerative diseases, and cancer, as well as developing therapeutic strategies targeting these pathways.
PubCompare.ai can help researchers optimize their pyruvate studies by locating the best protocols from literature, preprints, and patents, enhancing reproducibility and acuracy to advance this important area of biomedical research.
Most cited protocols related to «Pyruvate»
Most recents protocols related to «Pyruvate»
Example 2
BWZ/hTREM-1 reporter cell were cultured in RPMI 1640 w/o phenol red (Cat #11835, Gibco, Carlsbad Calif., USA), supplemented with 10% FCS (Cat #16140-071, Gibco, New York, USA), 1% Pen/Strep (Cat #15070-06, Gibco), 1 mM Sodium Pyruvate (Cat #11360, Gibco), 5 μM-2ME (Cat #31350-010, Gibco) and 2 mM L-Glutamine (Cat #25030, Gibco). No special plates or coating was required. 10 ml Versene (Cat #15040, Gibco) was added to detach the cells which then were transferred to tubes, centrifuged 1200 rpm 5 min and washed in fresh RPMI 1640 w/o phenol red. These cell were then ready to use in an assay or re-culture for further propagation.
Example 8
GiNOX, a water-forming NADH oxidase derived from Giardia intestinalis, and mitoGiNOX are capable of restoring the proliferation of mammalian cells cultured in pyruvate-depleted media and in the presence of antimycin, a complex III inhibitor. HeLa Tet3G cells cultured in the presence of varying concentrations of pyruvate demonstrated a diminished pyruvate-dependency in the presence of antimycin when GiNOX and mitoGiNOX were expressed in these cells (
Example 1
C57BL/6 mice were purchased from the National Cancer Institute, and all animal work was conducted in accordance with standard guidelines.
Cell lines Bosc23, PT67, GP+E86, EG7 (H-2b), and YAC-1 were obtained from the American Type Culture Collection (ATCC, Rockville, MD). RMA cells (H-2b) originated from a Rauscher virus-induced C57BL/6 T-cell lymphoma (Ljunggren and Karre (1985) J. Exp. Med. 162:1745-1759). RMAS-S is a sub-line of RMA which lacks MHC class-I surface expression (Karre, et al. (1986) Nature 319:675-678). All packaging cells were grown in Dulbecco's modified Eagle medium (DMEM) with a high glucose concentration (4.5 gram/liter) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Hyclone, Logan, UT), 20 U/mL penicillin, 20 μg/mL streptomycin, 1 mM pyruvate, 10 mM HEPES, 0.1 mM non-essential amino acids, 50 μM 2-mercaptoethanol. RMA, EG7, RMA-S and YAC-1 cells were cultured in RPMI plus the same supplements described above.
The reagents used were: Antimycin A, Sigma-Aldrich, A8674; Calcium Chloride dihydrate, Sigma-Aldrich, C3881; CHAPS hydrate, Sigma-Aldrich, C3023; Conjugated GFP antibody beads, Laboratory of Chris Ulens; D-Galactose, Sigma-Aldrich, G0750; D-glucose, Sigma-Aldrich, G7021-1KG; DAPI, Thermo Fisher Scientific, 62248; Dulbecco’s Modified Eagle’s Medium - high glucose, Sigma-Aldrich, D0422; EGTA, AppliChem, A0878; FCCP, Sigma-Aldrich, C2920; Gibco DMEM/F-12, Thermo Fisher Scientific, 11320074; Glucose, Agilent Seahorse, 103577; Glutamine, Sigma-Aldrich, G7513; Glutamine, Agilent Seahorse, 103579; GSK PERK Inhibitor, Toronto Research Company, G797800; Hygromycin B, Invivogen, ant-hg-1; Lipofectamine 2000 Transfection Reagent, Thermo Fisher Scientific, 11668019; MitoTracker FarRed, Thermo Fisher Scientific, M22426; NBD-PS, Avanti Polar Lipids, 810194C; SE Cell Line 4D-Nucleofector X Kit L, V4XC-1024; Oligomycin, Sigma-Aldrich, 75351; Penicillin and streptomycin, Sigma-Aldrich, P0781; Percoll, Sigma-Aldrich, P1644; Pierce ECL Western Blotting Substrate, Thermo Fisher Scientific, 32106X4; Pierce Protein A/G Magnetic Beads, Thermo Fisher Scientific, 88802; Pierce Protease Inhibitor Tablets, EDTA-free, Thermo Fisher Scientific, 88266; Potassium Chloride, Janssen Chimica, 7447407; Protease inhibitor, Thermo Fisher Scientific, A32953; Puromycin, Thermo Fisher Scientific, A11138-03; Protein A/G PLUS-Agarose, Santa Cruz, sc-2003; XF DMEM pH7 7.4, Agilent Seahorse, 103575; Sodium Chloride, Sigma-Aldrich, A0431796; Sodium Pyruvate Solution, Agilent Seahorse, 103578; Sucrose, Acros, A0333146; Thapsigargin, Enzo Life Sciences, BML-PE180; TransIT-X2 Dynamic Delivery System, Mirus Bio, MIR 6000; Tris base, Sigma-Aldrich, 77861; Triton, Sigma-Aldrich, T9234; Tween, Sigma Aldrich, P4780.
Top products related to «Pyruvate»
More about "Pyruvate"
It serves as a crucial intermediate in glycolysis and the citric acid cycle, and can be further metabolized to acetyl-CoA, lactate, or alanine.
Pyruvate research is crucial for understanding metabolic disorders, neurodegenerative diseases, and cancer, as well as developing therapeutic strategies targeting these pathways.
Sodium pyruvate, a salt form of pyruvate, is commonly used in cell culture media along with other supplements like fetal bovine serum (FBS), penicillin/streptomycin, L-glutamine, and non-essential amino acids.
These components help maintain cell health and support cellular processes.
Researchers can optimize their pyruvate studies by utilizing the insights and tools provided by PubCompare.ai.
This AI-driven platform can help locate the best protocols from literature, preprints, and patents, enhancing reproducibility and accuracy to advance this important area of biomedical research.
PubCompare.ai's comparisons can identify the most effective methods, ensuring researchers find the right approaches to study pyruvate and its role in cellular metabolism, mitochondrial function, and oxidative stress response.
By leveraging the power of PubCompare.ai, researchers can gain a deeper understanding of pyruvate's significance and develop more effective strategies for investigating metabolic disorders, neurodegenerative diseases, and cancer.
This knowledge can lead to the development of novel therapeutic interventions targeting the pyruvate pathways, ultimately improving patient outcomes and advancing the field of biomedical research.